[Progress in diagnosis and therapy: Hypocalcemia due to idiopathic hypoparathyroidism].
Tanaka
Hiroyuki
H
D000293:Adolescent; D000818:Animals; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics; D003937:Diagnosis, Differential; D050990:GATA3 Transcription Factor / Q000235:genetics; D017353:Gene Deletion; D006609:High Mobility Group Proteins / Q000235:genetics; D006801:Humans; D006887:Hydroxycholecalciferols / Q000008:administration & dosage; D006996:Hypocalcemia / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D007011:Hypoparathyroidism / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D018832:Molecular Chaperones / Q000235:genetics; D009687:Nuclear Proteins / Q000235:genetics; D010280:Parathyroid Glands / Q000196:embryology; D055748:SOXB1 Transcription Factors; D013577:Syndrome; D020825:T-Box Domain Proteins / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics
D004268:DNA-Binding Proteins; D050990:GATA3 Transcription Factor; C494749:GATA3 protein, human; C119532:GCM2 protein, human; D006609:High Mobility Group Proteins; D006887:Hydroxycholecalciferols; D018832:Molecular Chaperones; D009687:Nuclear Proteins; C527785:SOX3 protein, human; D055748:SOXB1 Transcription Factors; D020825:T-Box Domain Proteins; C469270:TBCE protein, human; C108625:TBX1 protein, human; D014157:Transcription Factors; C008088:alfacalcidol